Home Study Webcast
1 Contact Hour(s)
Friday, November 12, 2021
Sunday, November 12, 2023
ACPE Expiration Date
Sunday, May 12, 2024
In the wake of the COVID-19 pandemic, 2020 saw a 20% reduction in tuberculosis cases from 2019. This dramatic reduction is owed, in part, to pandemic mitigation procedures. However, as the United States investigates re-opening and resuming normal life, these TB infection numbers could increase as well, along with the likelihood of pharmacist being consulted on treatment.
This case-based investigation of TB will discuss the management of tuberculosis, latent tuberculosis infection (LTBI), and multidrug resistant tuberculosis (MDR-TB), as well as how to manage these conditions when drug-interactions are present.
PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.
In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.
PharmD, MPH, FCCP, BCIDP, BCPS, AAHIVP
Clinical Associate Professor, University of Illinois at Chicago, College of Pharmacy
This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).